Clinical Resources of Efficacy Evaluation Centers: How to Support "Repair" and "Anti-Aging" Claims?

In today's fiercely competitive international beauty market, a simple "repairs the barrier" or "anti-aging and firming" claim is no longer enough to impress overseas buyers. They don't just ask, "Does your product have this effect?" They ask, "Do you have the data to prove it?"

This is the core value of an Efficacy Evaluation Center.

I. Why "Claims" Are Worthless, But "Evidence" Is Invaluable

According to Grand View Research, the global anti-aging skincare market reached approximately $55.6 billion in 2025 and is projected to expand at a CAGR of 8.9% through 2033. This means every brand trying to capture a slice of this pie is competing with keywords like "anti-aging," "repair," and "firming." The larger the market, the more noise there is, and the higher the trust threshold for consumers and buyers.

As ingredient analysis and efficacy verification become the core basis for consumer decision-making, the focus of skincare competition has shifted from "marketing concepts" to "clear mechanisms, solid evidence, and authentic experiences." For OEM/ODM factories exporting or connecting with international brand clients, this is not a future trend; it is the reality happening right now.

Especially in European and American markets, DTC (Direct-to-Consumer) brands have increasingly refined requirements for their supply chains. They need more than just a beautiful formula; they need publicly available, regulatory-proof efficacy documentation.

II. China's Regulatory Framework: Which Claims Mandate Human Trials?

Many factory professionals still view Chinese regulations merely as a "filing" stage, but the compliance barriers for efficacy claims go far beyond that.

Under current regulations, cosmetics claiming spot whitening, sunscreen, anti-hair loss, anti-acne, nourishing, and repair must undergo human efficacy evaluation trials.

For "repair" claims, the core requirements for clinical efficacy evaluation include: clearly defining the skin sensitivity type and the mechanism of action (e.g., inhibiting inflammation, soothing sunburn, hydrating and calming, scavenging free radicals), measuring skin barrier repair and skin moisture content changes before and after the trial, and optionally combining this with provocative patch testing to comprehensively analyze objective and subjective data.

On the regulatory policy front, in November 2025, the National Medical Products Administration (NMPA) issued opinions on deepening regulatory reform, clarifying that, apart from spot whitening, sunscreen, and anti-hair loss claims, cosmetic registrants and filers are now allowed to independently choose the efficacy claim evaluation method. This policy relaxation gives factories greater flexibility—but it also means that the choice of evaluation method and the institution issuing the report will directly impact brand premium capabilities.

Furthermore, in February 2026, the Guiding Principles for Efficacy Claim Evaluation of Anti-Aging Cosmetics, spearheaded by the National Institutes for Food and Drug Control (NIFDC), officially entered the industry consultation phase. This marks a new era for anti-aging skincare claims, shifting from "concept marketing" to a dual focus on "scientific proof" and "ingredient compliance." For Chinese contract manufacturers targeting the international market, this is both pressure and opportunity: factories that establish evaluation systems first will build a deep compliance moat.

III. What Clinical Resources Can an Efficacy Evaluation Center Provide?

Professional efficacy evaluation centers typically provide the following core resources to directly support "repair" and "anti-aging" product claims:

1. In-vivo Human Studies

Human efficacy evaluation trials must be led by qualified medical institutions, pass ethics committee reviews, and obtain informed consent from subjects. This is the most credible and internationally recognized form of claim data. For "anti-aging" claims, a typical human trial design includes:

• Wrinkle Assessment: Using professional instruments like Derma-TOP HE or VISIOMETER VC20 to objectively quantify wrinkle improvement. This is combined with visual assessment (conducted by dermatologists or trained professionals) and volunteer self-assessment to form a multi-dimensional evaluation system.

• Skin Elasticity Measurement: Using a Cutometer to measure parameters like R2 (gross elasticity/elastic recovery rate). Percentage changes in these values can be directly used on product marketing pages.

• Skin Hydration Testing: Using a Corneometer to measure stratum corneum water content, comparing pre- and post-use changes to support "deep hydration" synergistic claims.

2. In-vitro / Ex-vivo Studies

For certain ingredient mechanisms, mechanistic evidence can be provided at the cellular or tissue level:

• Collagen Synthesis Testing: Evaluating the product's ability to promote Type I collagen generation through fibroblast stimulation assays, supporting "firming and lifting" claims.

• Antioxidant Capacity Testing: Data such as DPPH radical scavenging rates or ORAC values to support "antioxidant and anti-aging" claims.

• Barrier Repair Mechanism Testing: Evaluating the product's ability to repair barrier function using reconstructed skin models (e.g., EpiDerm™), which is one of the core experimental pathways supporting "repair" claims.

3. Consumer Perception Studies

Consumer surveys are one of the three major pillars supporting efficacy claims (alongside in-vivo and in-vitro testing). For overseas DTC websites, data generated from consumer surveys is highly practical. For example:

• "92% of subjects reported visibly firmer skin after 4 weeks of use."

• "88% of participants felt the product significantly improved facial dryness."

This type of data can be directly used on Landing Pages, product detail pages, and social media ads, yielding exceptionally high conversion rates.

IV. Matching Core Evidence to Claim Types

Below are recommended evaluation pathways for the two most common efficacy claims on DTC websites:

"Repair" Claims (e.g., repairing damaged barriers, soothing sensitivity)

• Core Metrics: Transepidermal Water Loss (TEWL) reduction rate, stratum corneum hydration changes, and skin redness index (Mexameter) changes.

• Timeline: This data is typically obtainable within a 4-week clinical trial cycle and can be directly used for mainstream international market claims like "repairs the barrier" or "strengthens skin defense."

"Anti-Aging" Claims (e.g., diminishing fine lines, improving firmness)

• Core Metrics: Wrinkle depth/area changes (image analysis reports), skin elasticity R2 value changes, and skin radiance parameter changes.

• Timeline & Rigor: Because anti-aging effects take time to manifest, clinical reports must be based on real subject data. Highly rigorous evaluation reports often combine clinical data issued by Tier 3 Grade A hospitals to enhance professional credibility. International brand clients typically require a minimum trial cycle of 8 weeks, with a sample size of no less than 30 subjects.

Are you looking for a reliable Skincare factory?

Are you seeking a trusted partner to launch or scale your skin care line? At Deva Skincare,we specialize in developing safe formulations that combine barrier science with clean, compliant manufacturing.

Our R&D team and certified production facilities deliver turnkey OEM/ODM solutions tailored to your target market’s regulatory and consumer expectations.

By collaborating with Deva Skincare, you gain access to industry-leading expertise and innovative formulations that set your brand apart in the competitive global market. Contact us today to discover how we can help you succeed.

V. How Can OEM/ODM Factories Transform Clinical Resources into Commercial Competitiveness?

Many factories already possess advantages in formulation and production, yet their external brand promotion materials still present nothing more than a list of raw material names and process descriptions. This yields very limited conversion rates on international DTC (Direct-to-Consumer) websites.

The truly persuasive marketing logic follows this chain: Ingredient → Mechanism → Clinical Data → Consumer Perception → Purchase Trust

The efficacy evaluation center serves as the crucial "conversion node" in this chain. It translates the active ingredients in a formulation into the numerical, data-driven language that buyers and consumers can easily understand and trust.

Practical Implementation Recommendations:

• During the Product Development Stage: Before finalizing the formulation, communicate with the evaluation center in advance to determine which efficacy claims are more easily validated through clinical trials. This helps avoid the risk of "mismatched claims and data" right from the source.

• When Pitching to Brand Clients: Provide a comprehensive Executive Summary of the efficacy evaluation report, highlighting key data milestones rather than presenting the entire technical document.